Interviews
On scientific creativity through analogical reasoning, virtual labs, multi-agent research, and the changing role of AI in science.
On Eroom’s Law, biological model validity, genetic reductionism, and the sociotechnical constraints on drug discovery and development.
How to pick the problems worth solving, biology's scaling laws, and what AI-driven science actually looks like in practice.
On building a machine learning-powered generative biology platform with the ability to create new drugs on demand across a wide range of biologic modalities.
On managing multidisciplinary teams, navigating the public markets, partnership mechanics with NVIDIA and Tempus and the future of spatial biology.